NCT00824473View on ClinicalTrials.gov

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

PHASE3CompletedINTERVENTIONAL
Enrollment

506

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

Placebo

Placebo

DRUG

0.15% azelastine hydrochloride

0.15% azelastine hydrochloride 822 mcg

Trial Locations (7)

76712

Allergy and Asthma Center, Waco

78130

Central Texas Health Research, New Braunfels

78229

Southwest Allergy and Asthma Center, P.A., San Antonio

Sylvana Research Associates, San Antonio

78258

Allergy, Asthma Research Center, San Antonio

78731

Allergy and Asthma Associates, Austin

78759

Allergy and Asthma Center of Austin, Austin

Sponsors
All Listed Sponsors
lead

Meda Pharmaceuticals

INDUSTRY